During an outbreak, it is critical to treat reusable medical devices as potential sources of transmission.
The latest regulations for human and veterinary medicinal products, as well as medical devices, include the mandate to set up databases with detailed information about available products. These databases must be realized and implemented in the near future, and require a concerted effort now if tangible real-world benefits are to follow.
A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
Patients are demanding the same type of convenience in healthcare management as they have in the rest of their daily lives.
2020 should be a pivotal year in which the microcosm of medical devices moves out of the shadows and joins the mainstream healthcare conversation.
The goal is to establish a baseline of cybersecurity hygiene and assurance for devices that are part of the national critical infrastructure software supply chain.
How will you make your company more attractive to investors?
When implementing IVDR requirements, it’s important to take a step back and look at the flow of documents.
Medtech companies must account for a more complex web of influencers on purchasing.
For too long this industry has lagged the pharma sector in terms of using data analytics to predict market trends. It’s time to change that.